Clinical biomarkers for thyroid immune-related adverse events in patients with stage III and IV gastrointestinal tumors
BackgroundThyroid immune-related adverse events (irAEs) associated with immune checkpoint inhibitor (ICI) treatment appear to correlate with a better prognosis. We aimed to investigate clinical biomarkers associated with thyroid irAEs.MethodsWe retrosp…